| 000 | 01878 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517210728.0 | ||
| 264 | 0 | _c20190624 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1029-2403 | ||
| 024 | 7 |
_a10.1080/10428194.2018.1452216 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKobulnicky, David J | |
| 245 | 0 | 0 |
_aThe influence of lymphoid reconstitution kinetics on clinical outcomes in allogeneic stem cell transplantation. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _c12 2018 |
||
| 300 |
_a2973-2981 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xblood |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xblood |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 |
_aLymphoid Tissue _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xepidemiology |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xmethods |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSabo, Roy T | |
| 700 | 1 | _aSharma, Shashank | |
| 700 | 1 | _aShubar Ali, Ali S | |
| 700 | 1 | _aKobulnicky, Kristen M | |
| 700 | 1 | _aRoberts, Catherine H | |
| 700 | 1 | _aClark, William B | |
| 700 | 1 | _aChung, Harold M | |
| 700 | 1 | _aMcCarty, John M | |
| 700 | 1 | _aToor, Amir A | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 59 _gno. 12 _gp. 2973-2981 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428194.2018.1452216 _zAvailable from publisher's website |
| 999 |
_c28249740 _d28249740 |
||